{"gene":"UCHL3","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":1997,"finding":"Crystal structure of human UCH-L3 at 1.8 Å resolution revealed a papain-like cysteine protease fold with catalytic triad Cys95, His169, Asp184 and oxyanion hole residue Gln89. The active site cleft is masked by two segments (residues 9-12 and 90-94) in the unliganded structure, implying a conformational change upon substrate binding.","method":"X-ray crystallography","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure at 1.8 Å with active site identification; foundational structural study replicated and extended by subsequent structures","pmids":["9233788"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of human UCH-L3 in complex with ubiquitin vinylmethylester (a suicide substrate) at 1.45 Å resolution confirmed the catalytic mechanism and revealed an active site crossover loop. UCH-L3 efficiently hydrolyzed a 13-residue peptide in isopeptide linkage with ubiquitin, demonstrating flexibility in substrate size acceptance.","method":"X-ray crystallography (1.45 Å), in vitro hydrolysis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution structure with covalent inhibitor complex plus in vitro functional assay; direct comparison of free and ligand-bound states","pmids":["15531586"],"is_preprint":false},{"year":1998,"finding":"UCH-L3 binds NEDD8 (as well as ubiquitin) and cleaves the C-terminus of NEDD8 in vitro, functioning as a C-terminal hydrolase for both ubiquitin and the ubiquitin-like protein NEDD8. UCH-L1 did not show this NEDD8 cleavage activity.","method":"Yeast two-hybrid, GST pull-down, in vitro cleavage assay with recombinant UCH-L3","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro cleavage assay with recombinant enzyme plus binding assay; replicated by multiple subsequent studies confirming dual ubiquitin/NEDD8 specificity","pmids":["9790970"],"is_preprint":false},{"year":1999,"finding":"NMR and site-directed mutagenesis identified the binding site on ubiquitin for UCH-L3: basic residues K6, K11, R72, and R74 on ubiquitin contact acidic residues E10, E14, D33, E219 on UCH-L3.","method":"Solution NMR, site-directed mutagenesis, X-ray crystallography-based modeling","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR mapping plus mutagenesis in a single study; orthogonal structural and biochemical methods","pmids":["10518943"],"is_preprint":false},{"year":2007,"finding":"UCH-L3 is the predominant active deubiquitinating enzyme in endosomal compartments of cortical collecting duct (CCD) epithelial cells. Blocking UCH-L3 activity or knockdown increased ENaC ubiquitination, removed ENaC from apical membranes, and reduced transepithelial Na+ currents, establishing UCH-L3 as a regulator of ENaC recycling.","method":"Activity-based chemical probe labeling, selective knockdown, surface biotinylation, whole-cell immunoprecipitation, electrophysiology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (chemical probe, siRNA knockdown, surface biotinylation, electrophysiology) in a single study with clear functional readout","pmids":["17967898"],"is_preprint":false},{"year":2008,"finding":"The active site crossover loop of UCH-L3 restricts access of bulky ubiquitin adducts to the active site. Physical integrity of the crossover loop is dispensable for catalysis per se, but enlarging it by mutation creates gain-of-function variants capable of cleaving polyubiquitin chains of various linkages that the wild-type enzyme cannot.","method":"Sortagging protein cleavage/tagging, active-site crossover loop mutagenesis, in vitro DUB activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis defining catalytic mechanism; novel sortagging technique plus functional assays","pmids":["19047059"],"is_preprint":false},{"year":2001,"finding":"Mice doubly homozygous for Uch-L1gad and Uch-L3Δ3-7 deletions show earlier lethality, dysphagia, and more severe axonal degeneration than either single mutant, demonstrating that UCH-L1 and UCH-L3 have both separate and overlapping (redundant) functions in neuronal maintenance. Uch-L3 single knockouts also show dorsal root ganglia degeneration.","method":"Genetic epistasis — double knockout mouse model, histological analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via double-knockout mice with defined histological and behavioral phenotypes; clearly establishes functional redundancy","pmids":["11555633"],"is_preprint":false},{"year":2006,"finding":"In Uchl3-deficient mice, UCH-L3 is normally enriched in photoreceptor inner segments. Loss of UCH-L3 leads to mitochondrial oxidative stress (increased MnSOD, cytochrome c oxidase I, AIF immunoreactivity) and caspase-independent photoreceptor apoptosis via endonuclease G nuclear translocation.","method":"Knockout mouse model, immunohistochemistry, electron microscopy, western blot for apoptosis markers","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout model with subcellular localization and multiple apoptosis markers; single lab study","pmids":["16816367"],"is_preprint":false},{"year":2008,"finding":"K48-linked ubiquitin dimers non-covalently interact with UCH-L3 in vitro and in cells, and these dimers potently inhibit UCH-L3 hydrolase activity; this regulatory interaction was not observed with UCH-L1, demonstrating a specific allosteric regulatory mechanism for UCH-L3.","method":"In vitro binding assay, cell-based co-immunoprecipitation, enzymatic activity assay","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — in vitro enzyme inhibition plus cellular Co-IP; single lab, two orthogonal methods","pmids":["19154770"],"is_preprint":false},{"year":2009,"finding":"UCH-L3 can fold and unfold reversibly in vitro without molecular chaperones, despite possessing the most complex knotted (5₂) topology known. Folding proceeds through two hyperfluorescent intermediates with a slow phase limited by proline isomerization.","method":"In vitro folding/unfolding equilibrium and kinetic experiments, fluorescence spectroscopy","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — rigorous in vitro folding study with multiple kinetic measurements; single lab","pmids":["19476499"],"is_preprint":false},{"year":2010,"finding":"Skeletal muscles of Uchl3-/- mice accumulate polyubiquitinated proteins and display ER stress and heat shock responses. Re-expression of wild-type but not hydrolase-inactive or ubiquitin-binding-deficient UCH-L3 rescued polyubiquitin accumulation in knockout MEFs, and wild-type UCH-L3 cleaved ubiquitin from polyubiquitinated lysozyme in vitro, confirming in vivo deubiquitinating function.","method":"Knockout mouse model, MEF rescue with wild-type vs. mutant UCH-L3, in vitro deubiquitination assay, western blot","journal":"Neurochemistry international","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro DUB assay plus active-site mutagenesis rescue in cells; multiple orthogonal methods establishing in vivo function","pmids":["20380862"],"is_preprint":false},{"year":2011,"finding":"UCH-L3 (and yeast ortholog YUH1) hydrolyzes the C-terminal extension of mutant ubiquitin UBB+1, yielding UB(G76Y); in vitro oxidation of recombinant UCH-L3 impairs its deubiquitinating activity, suggesting oxidative inactivation may contribute to UBB+1 accumulation in neurodegenerative disease.","method":"In vitro hydrolysis assay with recombinant enzyme, oxidation treatment of recombinant UCH-L3","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro enzymatic assay with oxidative modification; single lab, single method per finding","pmids":["21762696"],"is_preprint":false},{"year":2012,"finding":"UCHL3 associates with the meiotic spindle in oocytes (distinct from UCHL1 at the cortex). Microinjection of anti-UCHL3 antibodies disrupted oocyte maturation, caused abnormally long meiotic spindles, and blocked fertilization, establishing UCHL3 as required for proper meiotic spindle function and oocyte maturation.","method":"Microinjection of antibodies/inhibitors into GV oocytes, live-cell imaging, spindle morphology analysis","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by imaging plus functional antibody injection with defined phenotype; single lab","pmids":["21751213","21678411"],"is_preprint":false},{"year":2018,"finding":"UCHL3 deubiquitylates TDP1 (tyrosyl DNA phosphodiesterase 1), controlling its proteostasis. UCHL3 depletion increases TDP1 ubiquitylation and turnover, sensitizing cells to TOP1 poisons. Overexpression of catalytically active (but not inactive) UCHL3 suppresses TDP1 ubiquitylation. UCHL3 is downregulated in SCAN1, correlating with elevated TDP1 ubiquitylation.","method":"Knockdown and overexpression with catalytically inactive mutant controls, ubiquitylation assays, TOP1 poison sensitivity assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal gain/loss-of-function with catalytic mutant control, ubiquitylation assay, and disease-model correlation; multiple orthogonal validations","pmids":["29898404"],"is_preprint":false},{"year":2018,"finding":"UCHL3 interacts with and directly deubiquitylates Ku80, promoting Ku80 retention at DNA double-strand break sites. UCHL3 depletion reduces Ku80 foci and chromatin binding after DSB induction and decreases NHEJ efficiency. DNA damage induces ATM-dependent phosphorylation of UCHL3 (which destabilizes UCHL3 but does not affect its catalytic activity).","method":"Co-immunoprecipitation, in vitro deubiquitylation assay, laser micro-irradiation/ChIP, NHEJ reporter assay, kinase inhibitor studies","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct deubiquitylation assay plus reciprocal Co-IP plus functional NHEJ assay; multiple orthogonal methods","pmids":["30559450"],"is_preprint":false},{"year":2019,"finding":"UCHL3 deubiquitinates and stabilizes TRAF2 protein, activating NF-κB signaling to promote ovarian cancer tumorigenesis. Genetic ablation of UCHL3 blocked NF-κB activation and cancer cell proliferation/migration.","method":"Co-immunoprecipitation, in vitro deubiquitination assay, luciferase NF-κB reporter, knockdown/knockout, xenograft","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus deubiquitination assay plus pathway reporter; single lab","pmids":["31477831"],"is_preprint":false},{"year":2019,"finding":"UCHL3 deubiquitinates and stabilizes FOXM1 in pancreatic cancer cells, promoting proliferation, migration, invasion, and gemcitabine resistance. UCHL3 knockdown increased FOXM1 ubiquitination and turnover.","method":"Co-immunoprecipitation, in vitro deubiquitination assay, cycloheximide chase, xenograft mouse model","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, in vitro DUB assay, and protein stability assay; single lab with in vivo validation","pmids":["31598398"],"is_preprint":false},{"year":2019,"finding":"UCHL3 deubiquitinates RAD51 to promote its recruitment to DNA damage sites and augment homologous recombination repair. Perifosine (an Akt inhibitor) inhibits UCHL3 deubiquitination activity at low dose, induces RAD51 ubiquitination, blocks RAD51-BRCA2 interaction, and reduces IRIF of RAD51.","method":"In vitro DUB assay, ubiquitination assay, Co-IP, IRIF foci analysis, HR reporter, xenograft","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro DUB activity assay plus cellular HR assay; single lab","pmids":["31113933"],"is_preprint":false},{"year":2019,"finding":"UCHL3 deubiquitinates and stabilizes LSH (lymphoid-specific helicase chromatin remodeler) in non-small cell lung cancer cells; the lncRNA GIAT4RA counteracts this interaction by binding LSH and competing with UCHL3.","method":"Co-immunoprecipitation, ubiquitination assay, protein stability assay, knockdown/rescue","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and ubiquitination assays showing direct interaction; single lab","pmids":["31417184"],"is_preprint":false},{"year":2020,"finding":"UCHL3 interacts with, deubiquitylates, and stabilizes AhR (aryl hydrocarbon receptor) in NSCLC cells in a deubiquitylation activity-dependent manner, promoting stem-like gene expression (ABCG2, KLF4, c-Myc) and tumorigenic capacity.","method":"Co-immunoprecipitation, in vitro deubiquitylation assay, catalytic mutant controls, chromatin IP, knockdown/overexpression","journal":"Signal transduction and targeted therapy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, in vitro DUB assay, catalytic mutant, and ChIP; multiple orthogonal methods in one study","pmids":["32546741"],"is_preprint":false},{"year":2020,"finding":"UCHL3 deubiquitylates Aurora B (catalytic subunit of the chromosome passenger complex) and promotes Aurora B localization to kinetochores during mitosis. Downregulation or inhibition of UCHL3 causes chromosome alignment defects and segregation errors during metaphase/anaphase.","method":"Co-immunoprecipitation, deubiquitylation assay, immunofluorescence for kinetochore localization, siRNA knockdown, UCHL3 inhibition","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, DUB assay, and localization with functional mitotic phenotype; single lab","pmids":["32738097"],"is_preprint":false},{"year":2022,"finding":"Structural modeling and in vitro biochemistry showed that phosphorylation of UCHL3 at Ser75 (mimicked by S75E mutation) enhances deubiquitinating activity toward Ub-AMC and enables cleavage of K48-linked tetra-ubiquitin chains, which the wild-type enzyme cannot cleave at lower chain lengths.","method":"Structural simulation of phosphomimetic UCHL3S75E, crystal structure of UCHL3S75E-Ub-PA complex, in vitro DUB activity assay with di/tri/tetra-ubiquitin chains","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — structural analysis combined with in vitro enzymatic assay using phosphomimetic mutation; single lab","pmids":["36142702"],"is_preprint":false},{"year":2023,"finding":"UCHL3 deubiquitylates and stabilizes YAP in anaplastic thyroid cancer cells in a deubiquitylation activity-dependent manner. YAP/TEAD4 in turn transcriptionally activates UCHL3 expression, forming a positive feedback loop.","method":"Co-immunoprecipitation, deubiquitylation assay, UCHL3 promoter analysis, ChIP, knockdown/rescue","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, DUB assay, and promoter/ChIP analysis; single lab","pmids":["36813921"],"is_preprint":false},{"year":2023,"finding":"Mechanical force-stimulated macrophage-derived exosomes enriched in UCHL3 promote BMSC osteogenesis. Mechanistically, UCHL3 interacts with and stabilizes SMAD1 in BMSCs; UCHL3 inhibition downregulates SMAD1 and overexpression of SMAD1 rescues UCHL3-inhibition effects on osteogenesis.","method":"Proteomic analysis of exosomes, Co-immunoprecipitation, knockdown/rescue, in vivo orthodontic tooth movement model","journal":"Journal of nanobiotechnology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and rescue experiments with in vivo validation; single lab","pmids":["36915132"],"is_preprint":false},{"year":2023,"finding":"UCHL3 interacts with and deubiquitylates p300, leading to transcriptional activation of chemokines Ccl2, Ccl7, Ccl12 cooperatively with C/EBPβ, promoting M2 macrophage polarization and pulmonary fibrosis in alveolar type II cells.","method":"Co-immunoprecipitation, deubiquitination assay, ATII cell-specific knockout, transcriptional analysis","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, DUB assay, cell-specific KO with defined transcriptional and cellular phenotype; single lab","pmids":["37524875"],"is_preprint":false},{"year":2023,"finding":"Farrerol directly activates UCHL3 deubiquitinase activity, enhancing RAD51 deubiquitination and promoting homologous recombination repair. UCHL3 ablation significantly attenuates farrerol-mediated HR stimulation, identifying UCHL3 as the direct target of farrerol.","method":"Direct binding assay, in vitro DUB activity assay, HR reporter, UCHL3 knockout rescue experiment","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct target identification with in vitro activity assay and genetic ablation rescue; multiple orthogonal methods","pmids":["37012254"],"is_preprint":false},{"year":2023,"finding":"UCHL3 interacts with and deubiquitylates Vimentin (via K48-linked chains), enhancing its stability and promoting HCC cell migration; siRNA or TCID inhibitor-mediated suppression of UCHL3 upregulated ubiquitinated Vimentin.","method":"Co-immunoprecipitation, immunofluorescence, ubiquitination assay, siRNA knockdown, wound healing/Transwell assays","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP plus ubiquitination assay and functional migration assay; single lab","pmids":["36969045"],"is_preprint":false},{"year":2023,"finding":"UCHL3 interacts with and removes K48-linked poly-ubiquitin chains from β-catenin (ARM domain required), stabilizing β-catenin and activating Wnt/TCF target gene expression to promote HCC stem-like properties. UCHL3 depletion induces ferroptosis in HCC cells that is rescued by β-catenin overexpression.","method":"Co-immunoprecipitation, ubiquitination assay, TOP-luciferase reporter, domain mapping, knockdown/rescue","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination assay, domain mapping, and reporter assay; single lab","pmids":["38092274"],"is_preprint":false},{"year":2024,"finding":"UCHL3 deubiquitylates POLD4 (DNA polymerase delta subunit 4) in glioma stem cells, stabilizing it and promoting proneural-to-mesenchymal transition and radiation resistance via maintenance of HR and NHEJ repair.","method":"Co-immunoprecipitation, GST pull-down, deubiquitylation assay, in vitro/in vivo radiation assays, xenograft","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, GST pull-down, and DUB assay with in vivo validation; single lab","pmids":["38829550"],"is_preprint":false},{"year":2024,"finding":"UCHL3 stabilizes CTNNB1 (β-catenin) through deubiquitination, activating Wnt signaling in bladder cancer in a deubiquitylation activity-dependent manner. Uchl3-deficient mice are less susceptible to bladder tumorigenesis.","method":"CRISPR-Cas9 knockout/overexpression, Co-IP, RNA-seq, dual-luciferase Wnt reporter, conditional knockout mice","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus pathway reporter plus in vivo conditional KO; single lab","pmids":["37740194"],"is_preprint":false},{"year":2024,"finding":"UCHL3 deubiquitinates RIPK4 at the K469 site, removing K48-linked ubiquitin chains and stabilizing RIPK4. GSK3β-mediated phosphorylation of RIPK4 at Ser420 enhances its interaction with UCHL3, facilitating further deubiquitination and stabilization to promote ovarian cancer metastasis.","method":"Co-immunoprecipitation, ubiquitination assay, site-specific mutagenesis (K469, S420), TCID inhibitor treatment","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, site-specific mutagenesis, ubiquitination assay; single lab","pmids":["38664501"],"is_preprint":false},{"year":2024,"finding":"UCHL3 directly binds EEF1A1 at its lysine site and reduces EEF1A1 ubiquitination, stabilizing it; the UCHL3/EEF1A1 axis promotes HCC migration, stemness, and drug resistance.","method":"Co-immunoprecipitation, ubiquitination assay, cycloheximide chase, immunofluorescence, xenograft","journal":"Biology direct","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and ubiquitination assay with stability measurement; single lab","pmids":["38965582"],"is_preprint":false},{"year":2024,"finding":"Chemically constrained peptides identified by RaPID mRNA display bind PfUCHL3 with nanomolar affinity and selectively inhibit its deubiquitinase activity versus human UCHL3. NMR spectroscopy showed the peptides block ubiquitin substrate binding rather than occupying the active site.","method":"mRNA display (RaPID), NMR spectroscopy, in vitro DUB activity assay, selectivity profiling","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural mapping of binding site plus in vitro inhibition assay with selectivity data; multiple orthogonal methods","pmids":["38739798"],"is_preprint":false},{"year":2025,"finding":"UCHL3 removes K48-linked polyubiquitin chains from SIPA1 at lysine 805, protecting it from proteasomal degradation; ITCH E3 ligase antagonistically promotes SIPA1 ubiquitination. TRIM21 post-translationally targets UCHL3 for proteasomal degradation.","method":"Co-immunoprecipitation, ubiquitination assay, site-specific mutagenesis (K805), knockdown/rescue","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and ubiquitination assay with site-specific mutagenesis; single lab","pmids":["41412211"],"is_preprint":false},{"year":2025,"finding":"UCHL3 deubiquitinates and stabilizes PKM2 at K206 (C95A active-site mutant cannot do so), promoting pyruvate biosynthesis and augmenting cuproptosis in hepatocellular carcinoma.","method":"siRNA library screen, Co-IP, active-site mutagenesis (C95A), ubiquitinome profiling, site-specific mutagenesis (K206R), in vitro and in vivo cuproptosis assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — active-site mutagenesis plus site-specific substrate mutagenesis plus ubiquitinome profiling; single lab","pmids":["40451468"],"is_preprint":false},{"year":2025,"finding":"UCHL3 binds PACRG and stabilizes it via deubiquitination; DNAH10 exerts a bridging effect that enhances UCHL3-PACRG complex interaction to facilitate manchette function during spermiogenesis.","method":"Co-immunoprecipitation, deubiquitination assay, knockout mouse/cell models, localization studies","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and DUB assay with genetic model; single lab","pmids":["41058558"],"is_preprint":false},{"year":2025,"finding":"MC-LR directly binds the catalytic domain of UCHL3, blocking its interaction with GOPC and inhibiting its enzymatic activity, leading to excessive GOPC ubiquitination and proteasomal degradation, disrupting acrosome biogenesis.","method":"Direct binding assay, ubiquitination assay, proteasomal degradation assay, knockdown","journal":"Environmental pollution","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct binding and enzymatic inhibition with functional acrosome phenotype; single lab","pmids":["40784473"],"is_preprint":false},{"year":2025,"finding":"UCHL3 deubiquitinates and stabilizes HMGB1 by cleaving Lys48-linked polyubiquitin chains, promoting cytoplasmic HMGB1 accumulation, NCOA4-mediated ferritinophagy, and ferroptosis in nucleus pulposus cells.","method":"Co-immunoprecipitation, ubiquitination assay, transcriptomics, siRNA knockdown, in vivo disc degeneration model","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, ubiquitination assay, and in vivo model; single lab","pmids":["42169250"],"is_preprint":false},{"year":2025,"finding":"UCHL3 deubiquitinates TFEB, preventing its proteasomal degradation. DOX suppresses TFEB via UCHL3 downregulation, and 20-DOI counteracts DIC by restoring autophagic flux through UCHL3-mediated TFEB deubiquitination.","method":"Co-immunoprecipitation, siRNA knockdown, western blot, autophagic flux assays, in vivo MI/R model","journal":"Phytomedicine","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and functional autophagic assay with in vivo model; single lab","pmids":["40916238"],"is_preprint":false},{"year":2025,"finding":"Redox regulation: in S. cerevisiae, accumulated ROS during the diauxic shift inactivate Yuh1 (UCHL3 ortholog) via a thiol-based redox switch, reducing NEDD8/Rub1 maturation and affecting mitochondrial integrity.","method":"Yeast genetic model, redox biochemistry, mitochondrial function assays","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast ortholog study with defined redox mechanism and mitochondrial phenotype; single lab","pmids":["40347692"],"is_preprint":false},{"year":2025,"finding":"UCHL3 is activated upon flavivirus (ZIKV/DENV) infection; catalytically inactive UCHL3 C95A fails to rescue viral replication in UCHL3-KO cells. UCHL3 physically associates with sfRNA complexes and its loss accelerates RNase L-dependent sfRNA degradation from P-bodies to RLBs.","method":"CRISPR-Cas9 KO, reconstitution with WT vs. C95A mutant, proximity-biotinylation sfRNA-interactome capture, RNase L knockdown epistasis","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — catalytic mutant reconstitution plus proximity interactome plus genetic epistasis; single lab","pmids":["42231789"],"is_preprint":false},{"year":2025,"finding":"c/EBPβ transcriptionally upregulates Uchl3; UCHL3 then deubiquitinates TRPV1 and inhibits its proteasomal degradation in dorsal root ganglion neurons, stabilizing TRPV1 and promoting mitochondrial fission and neuropathic pain.","method":"Co-immunoprecipitation, ubiquitination assay, cycloheximide chase, luciferase assay, ChIP, CCI rat model with intrathecal siRNA","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, DUB assay, transcriptional assays, and in vivo pain model; single lab","pmids":["41864857"],"is_preprint":false},{"year":2025,"finding":"UCHL3 deubiquitinates and stabilizes ENO1 by removing K48-linked polyubiquitin chains at lysine 92; a C95A point mutation abolishes this activity. ENO1 stabilization activates the AKT/CCND1 pathway to drive gastric cancer progression.","method":"Co-immunoprecipitation, GST pull-down, site-specific mutagenesis (C95A, K92), cycloheximide chase, ubiquitination assay, molecular docking, PDX model","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — active-site and substrate-site mutagenesis, GST pull-down, ubiquitination assay, and in vivo PDX; multiple orthogonal methods","pmids":["41271634"],"is_preprint":false},{"year":2026,"finding":"Genetic lowering of UCHL3 in Huntington's disease neuronal models (primary mouse neurons, patient fibroblasts, patient-derived medium spiny neurons) decreased polyQ aggregates and increased autophagosome-lysosome fusion, accompanied by STAT3 induction. A small-molecule UCHL3 inhibitor recapitulated these neuroprotective effects.","method":"siRNA/genetic knockdown, small-molecule inhibitor treatment, autophagy flux assays, aggregate quantification in patient-derived neurons","journal":"Brain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological loss-of-function in disease-relevant neuronal models with defined mechanistic readouts; single lab","pmids":["41578740"],"is_preprint":false}],"current_model":"UCHL3 is a cysteine deubiquitylase (catalytic triad Cys95-His169-Asp184) and deNEDDylase that uses a crossover-loop-gated active site to cleave ubiquitin and NEDD8 from diverse substrates; phosphorylation of Ser75 and allosteric inhibition by K48-linked ubiquitin dimers modulate its chain-length preference, while its established substrates span DNA-repair factors (TDP1, RAD51, Ku80), oncoproteins (AhR, YAP, TRAF2, FOXM1, β-catenin/CTNNB1, RIPK4), cytoskeletal and metabolic proteins (Vimentin, ENO1, PKM2), signaling regulators (Aurora B, TRPV1, HMGB1, SMAD1, TFEB, PACRG), and ion-channel trafficking (ENaC), making UCHL3 a broad regulator of protein homeostasis in neurons, oocytes, muscle, and cancer cells."},"narrative":{"mechanistic_narrative":"UCHL3 is a papain-like cysteine deubiquitylase whose active site is built on a Cys95-His169-Asp184 catalytic triad with an oxyanion-hole glutamine (Gln89), and which hydrolyzes the C-terminus of both ubiquitin and the ubiquitin-like protein NEDD8, distinguishing it from its paralog UCHL1 [PMID:9233788, PMID:9790970]. Substrate access is governed by an active-site crossover loop that sterically restricts cleavage of bulky polyubiquitin adducts, such that wild-type UCHL3 favors small ubiquitin substrates while loop enlargement confers gain-of-function polyubiquitin chain cleavage [PMID:15531586, PMID:19047059]; this gating is modulated by phosphorylation at Ser75, which enhances activity and permits cleavage of K48-linked tetra-ubiquitin, and by allosteric inhibition from non-covalently bound K48-linked ubiquitin dimers [PMID:36142702, PMID:19154770]. The dominant cellular function emerging from the corpus is substrate stabilization: UCHL3 removes K48-linked degradative ubiquitin chains from a broad panel of client proteins, protecting them from proteasomal turnover in a catalysis-dependent manner. Through this activity UCHL3 stabilizes DNA-repair factors including TDP1, Ku80, and RAD51 to support topoisomerase-lesion repair, non-homologous end joining, and homologous recombination [PMID:29898404, PMID:30559450, PMID:31113933]. The same deubiquitylase logic drives its role in cancer, where it stabilizes oncogenic clients such as AhR, YAP, FOXM1, β-catenin/CTNNB1, ENO1, and TRAF2 to sustain proliferation, stemness, and survival signaling [PMID:32546741, PMID:32738097, PMID:36813921, PMID:38092274, PMID:37740194, PMID:41271634]. UCHL3 also regulates physiological homeostasis across tissues, controlling ENaC recycling in renal epithelium, meiotic spindle function in oocytes, and neuronal maintenance, where loss in mice causes axonal and dorsal root ganglia degeneration and accumulation of polyubiquitinated proteins [PMID:17967898, PMID:21751213, PMID:21678411, PMID:11555633, PMID:20380862]. Its activity is itself redox-sensitive, being impaired by oxidation of catalytic cysteine [PMID:21762696].","teleology":[{"year":1997,"claim":"Established the structural and catalytic basis of UCHL3 as a cysteine protease, defining the active-site architecture before any substrate was known.","evidence":"X-ray crystallography of human UCH-L3 at 1.8 Å resolving the Cys95-His169-Asp184 triad and a masked active-site cleft","pmids":["9233788"],"confidence":"High","gaps":["Unliganded structure did not capture the substrate-bound conformation","Did not define physiological substrates"]},{"year":1998,"claim":"Showed UCHL3 is a dual-specificity C-terminal hydrolase for ubiquitin and NEDD8, distinguishing it functionally from UCHL1.","evidence":"Yeast two-hybrid, GST pull-down, and in vitro cleavage assay with recombinant enzyme","pmids":["9790970"],"confidence":"High","gaps":["Did not establish cellular NEDD8 substrates","In vitro context only"]},{"year":2004,"claim":"Confirmed the catalytic mechanism with a covalent ubiquitin-suicide-substrate complex and revealed the active-site crossover loop plus tolerance for sizable leaving groups.","evidence":"X-ray crystallography at 1.45 Å of the ubiquitin-vinylmethylester adduct with in vitro isopeptide hydrolysis","pmids":["15531586"],"confidence":"High","gaps":["Did not address chain-linkage selectivity in cells"]},{"year":2008,"claim":"Defined the crossover loop as the determinant restricting polyubiquitin chain cleavage, explaining why wild-type UCHL3 prefers small substrates.","evidence":"Sortagging-based cleavage assays with crossover-loop mutagenesis and in vitro DUB activity tests","pmids":["19047059"],"confidence":"High","gaps":["Loop dynamics in the presence of physiological substrates not resolved"]},{"year":2008,"claim":"Identified an allosteric brake: K48-linked ubiquitin dimers inhibit UCHL3 specifically, providing a feedback mechanism on its activity.","evidence":"In vitro binding, cell-based Co-IP, and enzymatic activity assays","pmids":["19154770"],"confidence":"Medium","gaps":["Single lab; structural basis of the allosteric site not determined","In vivo relevance of dimer inhibition unestablished"]},{"year":2007,"claim":"Provided early in vivo function, showing UCHL3 controls ENaC deubiquitination and recycling in renal epithelium.","evidence":"Activity-based probe labeling, knockdown, surface biotinylation, and electrophysiology in CCD cells","pmids":["17967898"],"confidence":"High","gaps":["Direct deubiquitylation of ENaC not reconstituted in vitro"]},{"year":2010,"claim":"Demonstrated genuine in vivo deubiquitinating function required for proteostasis, since catalytically active enzyme is needed to clear polyubiquitin accumulation.","evidence":"Uchl3-/- mice, MEF rescue with wild-type vs catalytic/ubiquitin-binding mutants, and in vitro DUB assay","pmids":["20380862"],"confidence":"High","gaps":["Individual physiological substrates in muscle not identified"]},{"year":2006,"claim":"Linked UCHL3 loss to tissue-specific degeneration, implicating it in protection against oxidative-stress-driven apoptosis.","evidence":"Knockout mouse retina with IHC, EM, and apoptosis-marker westerns","pmids":["16816367"],"confidence":"Medium","gaps":["Mechanistic substrate linking UCHL3 to mitochondrial stress not defined"]},{"year":2018,"claim":"Initiated the substrate-stabilization paradigm by showing UCHL3 deubiquitylates DNA-repair factors to control their proteostasis and the DNA damage response.","evidence":"Reciprocal gain/loss-of-function with catalytic mutant controls, ubiquitylation assays, and TOP1-poison/NHEJ readouts for TDP1 and Ku80","pmids":["29898404","30559450"],"confidence":"High","gaps":["Direct cellular E3 ligases opposing UCHL3 on these substrates not fully mapped"]},{"year":2019,"claim":"Extended UCHL3 to homologous recombination and to oncogenic client stabilization, framing it as a druggable cancer dependency.","evidence":"In vitro DUB and ubiquitination assays, Co-IP, HR/NF-κB reporters and xenografts for RAD51, TRAF2, FOXM1, and LSH","pmids":["31113933","31477831","31598398","31417184"],"confidence":"Medium","gaps":["Most are single-lab studies","Direct vs indirect deubiquitylation not uniformly distinguished"]},{"year":2022,"claim":"Showed that Ser75 phosphorylation reprograms chain-length preference, providing a regulatory switch enabling K48 tetra-ubiquitin cleavage.","evidence":"Phosphomimetic S75E modeling, crystal structure of the S75E-Ub-PA complex, and in vitro DUB assays on di/tri/tetra-ubiquitin","pmids":["36142702"],"confidence":"Medium","gaps":["The physiological kinase for Ser75 not identified","Cellular consequences of S75 phosphorylation untested"]},{"year":2020,"claim":"Broadened UCHL3 substrates to mitotic and oncogenic regulators, reinforcing catalysis-dependent stabilization across pathways.","evidence":"Co-IP, DUB assays, catalytic-mutant controls, ChIP and localization for AhR and Aurora B","pmids":["32546741","32738097"],"confidence":"High","gaps":["Aurora B finding is single-lab","Linkage specificity on each substrate not always defined"]},{"year":2023,"claim":"Identified small molecules that directly modulate UCHL3 (activator farrerol) and consolidated its broad oncogenic and tissue-homeostasis substrate network.","evidence":"Direct binding/activity assays with KO rescue (farrerol/RAD51) plus Co-IP/DUB assays for YAP, Vimentin, β-catenin, SMAD1, p300, with in vivo models","pmids":["37012254","36813921","36969045","38092274","36915132","37524875"],"confidence":"Medium","gaps":["Many substrate studies are single-lab","Whether all clients are direct catalytic substrates not uniformly verified"]},{"year":2024,"claim":"Established site-specific deubiquitylation and upstream control of UCHL3, with K48-chain removal at defined substrate lysines and regulation of UCHL3 by phosphorylation and E3 ligases.","evidence":"Site-specific substrate mutagenesis (RIPK4-K469, SIPA1-K805), active-site mutants, and Co-IP across CTNNB1, POLD4, EEF1A1, RIPK4, SIPA1","pmids":["38664501","38829550","38965582","37740194","41412211"],"confidence":"Medium","gaps":["Single-lab substrate studies","Integration of competing E3 ligases into a unified regulatory model incomplete"]},{"year":2025,"claim":"Expanded UCHL3 into metabolism, ferroptosis/cuproptosis, antiviral defense, and disease models, and identified selective peptide and small-molecule modulators.","evidence":"Active-site mutant (C95A) and site-specific assays for PKM2/ENO1, ubiquitination/autophagy assays for HMGB1/TFEB/TRPV1/PACRG/GOPC, sfRNA interactome capture, and RaPID peptide inhibitors","pmids":["40451468","41271634","42169250","40916238","41864857","41058558","40784473","42231789","38739798"],"confidence":"Medium","gaps":["Mostly single-lab mechanistic claims","Direct vs scaffold roles in antiviral sfRNA protection not fully resolved"]},{"year":2026,"claim":"Linked UCHL3 activity to neurodegenerative proteostasis, showing its inhibition is neuroprotective in Huntington's disease models via enhanced autophagic clearance.","evidence":"Genetic and pharmacological loss-of-function in patient-derived neurons with aggregate and autophagy-flux readouts","pmids":["41578740"],"confidence":"Medium","gaps":["Direct UCHL3 substrate controlling autophagosome-lysosome fusion not identified","Single-lab study"]},{"year":null,"claim":"It remains unresolved how UCHL3's intrinsic small-substrate preference is reconciled with its many reported K48-polyubiquitin substrate-stabilization events, and which cellular signals (kinases, redox, allosteric ligands) select among its dozens of clients in a given tissue.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of substrate selectivity","Crossover-loop gating vs in-cell polyubiquitin cleavage not reconciled","Endogenous regulators of chain-length switching incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,5,10,13,14]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,2,5]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[2]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[13,14,17]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[12,20]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[13,14,17,28]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,10]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[19,20,22,27,29,42]}],"complexes":[],"partners":["TDP1","KU80","RAD51","AHR","YAP","CTNNB1","ENO1","TRAF2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P15374","full_name":"Ubiquitin carboxyl-terminal hydrolase isozyme L3","aliases":["Ubiquitin thioesterase L3"],"length_aa":230,"mass_kda":26.2,"function":"Deubiquitinating enzyme (DUB) that controls levels of cellular ubiquitin through processing of ubiquitin precursors and ubiquitinated proteins. Thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of either ubiquitin or NEDD8. Has a 10-fold preference for Arg and Lys at position P3'', and exhibits a preference towards 'Lys-48'-linked ubiquitin chains. Deubiquitinates ENAC in apical compartments, thereby regulating apical membrane recycling. Indirectly increases the phosphorylation of IGFIR, AKT and FOXO1 and promotes insulin-signaling and insulin-induced adipogenesis. Required for stress-response retinal, skeletal muscle and germ cell maintenance. May be involved in working memory. Can hydrolyze UBB(+1), a mutated form of ubiquitin which is not effectively degraded by the proteasome and is associated with neurodegenerative disorders","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P15374/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/UCHL3","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/UCHL3","total_profiled":1310},"omim":[{"mim_id":"609113","title":"TELOMERE LENGTH, MEAN LEUKOCYTE; LTL","url":"https://www.omim.org/entry/609113"},{"mim_id":"607047","title":"ATAXIN 3; ATXN3","url":"https://www.omim.org/entry/607047"},{"mim_id":"604362","title":"LIM DOMAIN ONLY 7; LMO7","url":"https://www.omim.org/entry/604362"},{"mim_id":"603090","title":"UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3; UCHL3","url":"https://www.omim.org/entry/603090"},{"mim_id":"603089","title":"BRCA1-ASSOCIATED PROTEIN 1; BAP1","url":"https://www.omim.org/entry/603089"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/UCHL3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P15374","domains":[{"cath_id":"3.40.532.10","chopping":"12-228","consensus_level":"medium","plddt":95.4817,"start":12,"end":228}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P15374","model_url":"https://alphafold.ebi.ac.uk/files/AF-P15374-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P15374-F1-predicted_aligned_error_v6.png","plddt_mean":94.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=UCHL3","jax_strain_url":"https://www.jax.org/strain/search?query=UCHL3"},"sequence":{"accession":"P15374","fasta_url":"https://rest.uniprot.org/uniprotkb/P15374.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P15374/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P15374"}},"corpus_meta":[{"pmid":"9233788","id":"PMC_9233788","title":"Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9233788","citation_count":217,"is_preprint":false},{"pmid":"15531586","id":"PMC_15531586","title":"Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15531586","citation_count":166,"is_preprint":false},{"pmid":"9790970","id":"PMC_9790970","title":"Cleavage of the C-terminus of NEDD8 by UCH-L3.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9790970","citation_count":137,"is_preprint":false},{"pmid":"17967898","id":"PMC_17967898","title":"The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17967898","citation_count":87,"is_preprint":false},{"pmid":"11555633","id":"PMC_11555633","title":"Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11555633","citation_count":81,"is_preprint":false},{"pmid":"17371404","id":"PMC_17371404","title":"Apicomplexan UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout evolution.","date":"2007","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17371404","citation_count":78,"is_preprint":false},{"pmid":"32546741","id":"PMC_32546741","title":"The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor.","date":"2020","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32546741","citation_count":77,"is_preprint":false},{"pmid":"10713173","id":"PMC_10713173","title":"Expression and functional analysis of Uch-L3 during mouse development.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10713173","citation_count":65,"is_preprint":false},{"pmid":"12761045","id":"PMC_12761045","title":"An engineered 800 kilobase deletion of Uchl3 and Lmo7 on mouse chromosome 14 causes defects in viability, postnatal growth and degeneration of muscle and retina.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12761045","citation_count":62,"is_preprint":false},{"pmid":"15884048","id":"PMC_15884048","title":"Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory.","date":"2005","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/15884048","citation_count":56,"is_preprint":false},{"pmid":"31477831","id":"PMC_31477831","title":"UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31477831","citation_count":54,"is_preprint":false},{"pmid":"16816367","id":"PMC_16816367","title":"Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice.","date":"2006","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16816367","citation_count":54,"is_preprint":false},{"pmid":"19047059","id":"PMC_19047059","title":"Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19047059","citation_count":54,"is_preprint":false},{"pmid":"20042598","id":"PMC_20042598","title":"Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20042598","citation_count":53,"is_preprint":false},{"pmid":"31598398","id":"PMC_31598398","title":"UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31598398","citation_count":52,"is_preprint":false},{"pmid":"21751213","id":"PMC_21751213","title":"Essential role of ubiquitin C-terminal hydrolases UCHL1 and UCHL3 in mammalian oocyte maturation.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21751213","citation_count":52,"is_preprint":false},{"pmid":"29898404","id":"PMC_29898404","title":"UCHL3 Regulates Topoisomerase-Induced Chromosomal Break Repair by Controlling TDP1 Proteostasis.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29898404","citation_count":51,"is_preprint":false},{"pmid":"21678411","id":"PMC_21678411","title":"Essential role of maternal UCHL1 and UCHL3 in fertilization and preimplantation embryo development.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21678411","citation_count":51,"is_preprint":false},{"pmid":"19476499","id":"PMC_19476499","title":"Untangling the folding mechanism of the 5(2)-knotted protein UCH-L3.","date":"2009","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/19476499","citation_count":50,"is_preprint":false},{"pmid":"36813921","id":"PMC_36813921","title":"The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/36813921","citation_count":49,"is_preprint":false},{"pmid":"15963938","id":"PMC_15963938","title":"Synthesis and characterization of fluorescent ubiquitin derivatives as highly sensitive substrates for the deubiquitinating enzymes UCH-L3 and USP-2.","date":"2005","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15963938","citation_count":47,"is_preprint":false},{"pmid":"30559450","id":"PMC_30559450","title":"The deubiquitylating enzyme UCHL3 regulates Ku80 retention at sites of DNA damage.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30559450","citation_count":46,"is_preprint":false},{"pmid":"36915132","id":"PMC_36915132","title":"Mechanical force induces macrophage-derived exosomal UCHL3 promoting bone marrow mesenchymal stem cell osteogenesis by targeting SMAD1.","date":"2023","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36915132","citation_count":44,"is_preprint":false},{"pmid":"31417184","id":"PMC_31417184","title":"GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31417184","citation_count":42,"is_preprint":false},{"pmid":"31113933","id":"PMC_31113933","title":"A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31113933","citation_count":41,"is_preprint":false},{"pmid":"21762696","id":"PMC_21762696","title":"Mutant ubiquitin (UBB+1) associated with neurodegenerative disorders is hydrolyzed by ubiquitin C-terminal hydrolase L3 (UCH-L3).","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21762696","citation_count":40,"is_preprint":false},{"pmid":"10518943","id":"PMC_10518943","title":"The binding site for UCH-L3 on ubiquitin: mutagenesis and NMR studies on the complex between ubiquitin and UCH-L3.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10518943","citation_count":33,"is_preprint":false},{"pmid":"33194042","id":"PMC_33194042","title":"UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT/mTOR signaling pathway.","date":"2020","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/33194042","citation_count":31,"is_preprint":false},{"pmid":"19154770","id":"PMC_19154770","title":"Ubiquitin dimers control the hydrolase activity of UCH-L3.","date":"2008","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/19154770","citation_count":28,"is_preprint":false},{"pmid":"33616859","id":"PMC_33616859","title":"UCHL3 promotes aerobic glycolysis of pancreatic cancer through upregulating LDHA expression.","date":"2021","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/33616859","citation_count":26,"is_preprint":false},{"pmid":"18307031","id":"PMC_18307031","title":"The hippocampal proteomic analysis of senescence-accelerated mouse: implications of Uchl3 and mitofilin in cognitive disorder and mitochondria dysfunction in SAMP8.","date":"2008","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/18307031","citation_count":26,"is_preprint":false},{"pmid":"37012254","id":"PMC_37012254","title":"Farrerol directly activates the deubiqutinase UCHL3 to promote DNA repair and reprogramming when mediated by somatic cell nuclear transfer.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37012254","citation_count":21,"is_preprint":false},{"pmid":"35918714","id":"PMC_35918714","title":"LINC00665 knockdown confers sensitivity in irradiated non-small cell lung cancer cells through the miR-582-5p/UCHL3/AhR axis.","date":"2022","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35918714","citation_count":21,"is_preprint":false},{"pmid":"20380862","id":"PMC_20380862","title":"Skeletal muscles of Uchl3 knockout mice show polyubiquitinated protein accumulation and stress responses.","date":"2010","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/20380862","citation_count":21,"is_preprint":false},{"pmid":"38092274","id":"PMC_38092274","title":"UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38092274","citation_count":19,"is_preprint":false},{"pmid":"34745437","id":"PMC_34745437","title":"UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3 K/Akt signaling pathway in prostate cancer cells.","date":"2021","source":"Animal cells and systems","url":"https://pubmed.ncbi.nlm.nih.gov/34745437","citation_count":18,"is_preprint":false},{"pmid":"37524875","id":"PMC_37524875","title":"The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis.","date":"2023","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37524875","citation_count":17,"is_preprint":false},{"pmid":"34752952","id":"PMC_34752952","title":"UCH-L3 structure and function: Insights about a promising drug target.","date":"2021","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34752952","citation_count":16,"is_preprint":false},{"pmid":"11341770","id":"PMC_11341770","title":"Cloning, expression, and mapping of a mouse gene, Uchl4, highly homologous to human and mouse Uchl3.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11341770","citation_count":16,"is_preprint":false},{"pmid":"36969045","id":"PMC_36969045","title":"UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36969045","citation_count":15,"is_preprint":false},{"pmid":"34016790","id":"PMC_34016790","title":"Silencing UCHL3 enhances radio-sensitivity of non-small cell lung cancer cells by inhibiting DNA repair.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34016790","citation_count":15,"is_preprint":false},{"pmid":"37740194","id":"PMC_37740194","title":"Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37740194","citation_count":14,"is_preprint":false},{"pmid":"40487654","id":"PMC_40487654","title":"Targeting the JAK2-STAT3-UCHL3-ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer.","date":"2025","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/40487654","citation_count":13,"is_preprint":false},{"pmid":"32180254","id":"PMC_32180254","title":"UCH-L3 promotes non-small cell lung cancer proliferation via accelerating cell cycle and inhibiting cell apoptosis.","date":"2020","source":"Biotechnology and applied biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32180254","citation_count":11,"is_preprint":false},{"pmid":"38829550","id":"PMC_38829550","title":"UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/38829550","citation_count":10,"is_preprint":false},{"pmid":"38965582","id":"PMC_38965582","title":"UCHL3 promotes hepatocellular carcinoma progression by stabilizing EEF1A1 through deubiquitination.","date":"2024","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/38965582","citation_count":10,"is_preprint":false},{"pmid":"36142702","id":"PMC_36142702","title":"Structural Insights into the Phosphorylation-Enhanced Deubiquitinating Activity of UCHL3 and Ubiquitin Chain Cleavage Preference Analysis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36142702","citation_count":10,"is_preprint":false},{"pmid":"34539860","id":"PMC_34539860","title":"UCHL3 plays an important role in the occurrence and development of melanoma.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34539860","citation_count":10,"is_preprint":false},{"pmid":"36527747","id":"PMC_36527747","title":"UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36527747","citation_count":9,"is_preprint":false},{"pmid":"35088238","id":"PMC_35088238","title":"Knockdown of UCHL3 inhibits esophageal squamous cell carcinoma progression by reducing CRY2 methylation.","date":"2022","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/35088238","citation_count":9,"is_preprint":false},{"pmid":"38187053","id":"PMC_38187053","title":"Porphyromonas gingivalis induced UCHL3 to promote colon cancer progression.","date":"2023","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38187053","citation_count":9,"is_preprint":false},{"pmid":"32738097","id":"PMC_32738097","title":"Deubiquitylase UCHL3 regulates bi-orientation and segregation of chromosomes during mitosis.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32738097","citation_count":9,"is_preprint":false},{"pmid":"38266402","id":"PMC_38266402","title":"UCHL-3 as a potential biomarker of ovarian cancer.","date":"2024","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38266402","citation_count":8,"is_preprint":false},{"pmid":"10527871","id":"PMC_10527871","title":"Molecular cloning of chick UCH-6 which shares high similarity with human UCH-L3: its unusual substrate specificity and tissue distribution.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10527871","citation_count":7,"is_preprint":false},{"pmid":"17211910","id":"PMC_17211910","title":"Ubiquitin binds to a short peptide segment of hydrolase UCH-L3: a study by FCS, RIfS, ITC and NMR.","date":"2007","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/17211910","citation_count":7,"is_preprint":false},{"pmid":"34238144","id":"PMC_34238144","title":"Friend or Foe: UCHL3 Mediated Carcinogenesis and Current Approaches in Small Molecule Inhibitors' Development.","date":"2021","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34238144","citation_count":6,"is_preprint":false},{"pmid":"40451467","id":"PMC_40451467","title":"The peptide from C- Phycocyanin alleviates myocardial ischemia-reperfusion injury by suppressing ferroptosis via upregulating UCHL3.","date":"2025","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40451467","citation_count":6,"is_preprint":false},{"pmid":"38474064","id":"PMC_38474064","title":"CircMTA2 Drives Gastric Cancer Progression through Suppressing MTA2 Degradation via Interacting with UCHL3.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38474064","citation_count":6,"is_preprint":false},{"pmid":"38664501","id":"PMC_38664501","title":"GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer.","date":"2024","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/38664501","citation_count":5,"is_preprint":false},{"pmid":"39226739","id":"PMC_39226739","title":"Role of UCHL3 in health and disease.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39226739","citation_count":5,"is_preprint":false},{"pmid":"18202904","id":"PMC_18202904","title":"cDNA cloning, sequence identification and tissue expression distribution of three novel porcine genes: UCHL3, RIT1 and CCND3.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18202904","citation_count":5,"is_preprint":false},{"pmid":"32851933","id":"PMC_32851933","title":"Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors via virtual screening, molecular dynamics and binding mode analysis.","date":"2020","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/32851933","citation_count":5,"is_preprint":false},{"pmid":"40389047","id":"PMC_40389047","title":"Morin induces autophagy-dependent ferroptosis in colorectal cancer cells by inhibiting the AURKB-UCHL3 interactions.","date":"2025","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/40389047","citation_count":4,"is_preprint":false},{"pmid":"38739798","id":"PMC_38739798","title":"Targeting the Plasmodium falciparum UCHL3 ubiquitin hydrolase using chemically constrained peptides.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38739798","citation_count":4,"is_preprint":false},{"pmid":"31642235","id":"PMC_31642235","title":"[UCH-L3 Expression in Epithelial Ovarian Cancer and Its Clinical Significance].","date":"2019","source":"Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition","url":"https://pubmed.ncbi.nlm.nih.gov/31642235","citation_count":4,"is_preprint":false},{"pmid":"40451468","id":"PMC_40451468","title":"UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma.","date":"2025","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40451468","citation_count":3,"is_preprint":false},{"pmid":"40691601","id":"PMC_40691601","title":"UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression.","date":"2025","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/40691601","citation_count":3,"is_preprint":false},{"pmid":"19636824","id":"PMC_19636824","title":"Backbone 1H, 13C, and 15N resonance assignments for the 26-kD human de-ubiquitinating enzyme UCH-L3.","date":"2007","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/19636824","citation_count":3,"is_preprint":false},{"pmid":"41412211","id":"PMC_41412211","title":"A TRIM21-UCHL3-ITCH-SIPA1 axis promotes colorectal cancer growth and metastasis.","date":"2025","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/41412211","citation_count":1,"is_preprint":false},{"pmid":"40916238","id":"PMC_40916238","title":"20-Deoxyingenol attenuated doxorubicin-induced cardiotoxicity by promoting autolysosome degradation through the UCHL3-TFEB pathway.","date":"2025","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40916238","citation_count":1,"is_preprint":false},{"pmid":"39651760","id":"PMC_39651760","title":"Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology.","date":"2024","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/39651760","citation_count":1,"is_preprint":false},{"pmid":"40784473","id":"PMC_40784473","title":"UCHL3-mediated proteasomal degradation of GOPC drives microcystin-LR-induced acrosomal dysgenesis.","date":"2025","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/40784473","citation_count":1,"is_preprint":false},{"pmid":"40002753","id":"PMC_40002753","title":"Investigation of UCHL3 and HNMT Gene Polymorphisms in Greek Patients with Type 2 Diabetes Mellitus and Diabetic Retinopathy.","date":"2025","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/40002753","citation_count":1,"is_preprint":false},{"pmid":"41271634","id":"PMC_41271634","title":"UCHL3 depletion inhibits gastric cancer progression and enhances palbociclib sensitivity by regulating the AKT/CCND1 signaling axis via ENO1 ubiquitination.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41271634","citation_count":0,"is_preprint":false},{"pmid":"40394598","id":"PMC_40394598","title":"Exploring the mechanism by which UCHL3 alleviates diabetic foot ulcers: FOXM1/NLRP3 inflammasome-mediated angiogenesis and endothelial cell pyroptosis.","date":"2025","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/40394598","citation_count":0,"is_preprint":false},{"pmid":"40347692","id":"PMC_40347692","title":"Redox-driven regulation of UCHL3/Yuh1 influences mitochondrial health via the NEDD8/Rub1 pathway.","date":"2025","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/40347692","citation_count":0,"is_preprint":false},{"pmid":"40689350","id":"PMC_40689350","title":"UCHL3 regulates snail stability and promotes epithelial-mesenchymal transition in ovarian cancer.","date":"2025","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/40689350","citation_count":0,"is_preprint":false},{"pmid":"41578740","id":"PMC_41578740","title":"Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease.","date":"2026","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/41578740","citation_count":0,"is_preprint":false},{"pmid":"42169250","id":"PMC_42169250","title":"UCHL3 drives ferroptosis in nucleus pulposus cells by deubiquitinating HMGB1 to activate NCOA4-mediated ferritinophagy.","date":"2026","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/42169250","citation_count":0,"is_preprint":false},{"pmid":"41945287","id":"PMC_41945287","title":"UCHL3 Promotes Triple-Negative Breast Cancer Metastatic Potential Through Enhancing Cell Migration and Invasion.","date":"2026","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41945287","citation_count":0,"is_preprint":false},{"pmid":"41058558","id":"PMC_41058558","title":"DNAH10 interacts with UCHL3-PACRG complex to coordinate sperm head and flagella development during spermiogenesis.","date":"2025","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/41058558","citation_count":0,"is_preprint":false},{"pmid":"41864557","id":"PMC_41864557","title":"c/EBPβ-driven Uchl3-mediated deubiquitination of TRPV1 promotes neuropathic pain by inducing mitochondrial fission in male rats.","date":"2026","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41864557","citation_count":0,"is_preprint":false},{"pmid":"42231789","id":"PMC_42231789","title":"UCHL3 Regulates Subgenomic Flaviviral RNA Condensates to Promote Virus Propagation.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/42231789","citation_count":0,"is_preprint":false},{"pmid":"41492038","id":"PMC_41492038","title":"ACTG1 promotes breast cancer aggressiveness and confers ribociclib resistance by deubiquitinating HSPA8 through UCHL3.","date":"2026","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/41492038","citation_count":0,"is_preprint":false},{"pmid":"30111405","id":"PMC_30111405","title":"[Autophagy and Expression of UCH-L3 Induced by Rapamycin in HL-60 Cells].","date":"2018","source":"Zhongguo shi yan xue ye xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/30111405","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43827,"output_tokens":10083,"usd":0.141363,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20513,"output_tokens":4941,"usd":0.113045,"stage2_stop_reason":"end_turn"},"total_usd":0.254408,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Crystal structure of human UCH-L3 at 1.8 Å resolution revealed a papain-like cysteine protease fold with catalytic triad Cys95, His169, Asp184 and oxyanion hole residue Gln89. The active site cleft is masked by two segments (residues 9-12 and 90-94) in the unliganded structure, implying a conformational change upon substrate binding.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure at 1.8 Å with active site identification; foundational structural study replicated and extended by subsequent structures\",\n      \"pmids\": [\"9233788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of human UCH-L3 in complex with ubiquitin vinylmethylester (a suicide substrate) at 1.45 Å resolution confirmed the catalytic mechanism and revealed an active site crossover loop. UCH-L3 efficiently hydrolyzed a 13-residue peptide in isopeptide linkage with ubiquitin, demonstrating flexibility in substrate size acceptance.\",\n      \"method\": \"X-ray crystallography (1.45 Å), in vitro hydrolysis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution structure with covalent inhibitor complex plus in vitro functional assay; direct comparison of free and ligand-bound states\",\n      \"pmids\": [\"15531586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"UCH-L3 binds NEDD8 (as well as ubiquitin) and cleaves the C-terminus of NEDD8 in vitro, functioning as a C-terminal hydrolase for both ubiquitin and the ubiquitin-like protein NEDD8. UCH-L1 did not show this NEDD8 cleavage activity.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, in vitro cleavage assay with recombinant UCH-L3\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro cleavage assay with recombinant enzyme plus binding assay; replicated by multiple subsequent studies confirming dual ubiquitin/NEDD8 specificity\",\n      \"pmids\": [\"9790970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NMR and site-directed mutagenesis identified the binding site on ubiquitin for UCH-L3: basic residues K6, K11, R72, and R74 on ubiquitin contact acidic residues E10, E14, D33, E219 on UCH-L3.\",\n      \"method\": \"Solution NMR, site-directed mutagenesis, X-ray crystallography-based modeling\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR mapping plus mutagenesis in a single study; orthogonal structural and biochemical methods\",\n      \"pmids\": [\"10518943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"UCH-L3 is the predominant active deubiquitinating enzyme in endosomal compartments of cortical collecting duct (CCD) epithelial cells. Blocking UCH-L3 activity or knockdown increased ENaC ubiquitination, removed ENaC from apical membranes, and reduced transepithelial Na+ currents, establishing UCH-L3 as a regulator of ENaC recycling.\",\n      \"method\": \"Activity-based chemical probe labeling, selective knockdown, surface biotinylation, whole-cell immunoprecipitation, electrophysiology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (chemical probe, siRNA knockdown, surface biotinylation, electrophysiology) in a single study with clear functional readout\",\n      \"pmids\": [\"17967898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The active site crossover loop of UCH-L3 restricts access of bulky ubiquitin adducts to the active site. Physical integrity of the crossover loop is dispensable for catalysis per se, but enlarging it by mutation creates gain-of-function variants capable of cleaving polyubiquitin chains of various linkages that the wild-type enzyme cannot.\",\n      \"method\": \"Sortagging protein cleavage/tagging, active-site crossover loop mutagenesis, in vitro DUB activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis defining catalytic mechanism; novel sortagging technique plus functional assays\",\n      \"pmids\": [\"19047059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mice doubly homozygous for Uch-L1gad and Uch-L3Δ3-7 deletions show earlier lethality, dysphagia, and more severe axonal degeneration than either single mutant, demonstrating that UCH-L1 and UCH-L3 have both separate and overlapping (redundant) functions in neuronal maintenance. Uch-L3 single knockouts also show dorsal root ganglia degeneration.\",\n      \"method\": \"Genetic epistasis — double knockout mouse model, histological analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via double-knockout mice with defined histological and behavioral phenotypes; clearly establishes functional redundancy\",\n      \"pmids\": [\"11555633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In Uchl3-deficient mice, UCH-L3 is normally enriched in photoreceptor inner segments. Loss of UCH-L3 leads to mitochondrial oxidative stress (increased MnSOD, cytochrome c oxidase I, AIF immunoreactivity) and caspase-independent photoreceptor apoptosis via endonuclease G nuclear translocation.\",\n      \"method\": \"Knockout mouse model, immunohistochemistry, electron microscopy, western blot for apoptosis markers\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout model with subcellular localization and multiple apoptosis markers; single lab study\",\n      \"pmids\": [\"16816367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"K48-linked ubiquitin dimers non-covalently interact with UCH-L3 in vitro and in cells, and these dimers potently inhibit UCH-L3 hydrolase activity; this regulatory interaction was not observed with UCH-L1, demonstrating a specific allosteric regulatory mechanism for UCH-L3.\",\n      \"method\": \"In vitro binding assay, cell-based co-immunoprecipitation, enzymatic activity assay\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — in vitro enzyme inhibition plus cellular Co-IP; single lab, two orthogonal methods\",\n      \"pmids\": [\"19154770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"UCH-L3 can fold and unfold reversibly in vitro without molecular chaperones, despite possessing the most complex knotted (5₂) topology known. Folding proceeds through two hyperfluorescent intermediates with a slow phase limited by proline isomerization.\",\n      \"method\": \"In vitro folding/unfolding equilibrium and kinetic experiments, fluorescence spectroscopy\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — rigorous in vitro folding study with multiple kinetic measurements; single lab\",\n      \"pmids\": [\"19476499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Skeletal muscles of Uchl3-/- mice accumulate polyubiquitinated proteins and display ER stress and heat shock responses. Re-expression of wild-type but not hydrolase-inactive or ubiquitin-binding-deficient UCH-L3 rescued polyubiquitin accumulation in knockout MEFs, and wild-type UCH-L3 cleaved ubiquitin from polyubiquitinated lysozyme in vitro, confirming in vivo deubiquitinating function.\",\n      \"method\": \"Knockout mouse model, MEF rescue with wild-type vs. mutant UCH-L3, in vitro deubiquitination assay, western blot\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro DUB assay plus active-site mutagenesis rescue in cells; multiple orthogonal methods establishing in vivo function\",\n      \"pmids\": [\"20380862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"UCH-L3 (and yeast ortholog YUH1) hydrolyzes the C-terminal extension of mutant ubiquitin UBB+1, yielding UB(G76Y); in vitro oxidation of recombinant UCH-L3 impairs its deubiquitinating activity, suggesting oxidative inactivation may contribute to UBB+1 accumulation in neurodegenerative disease.\",\n      \"method\": \"In vitro hydrolysis assay with recombinant enzyme, oxidation treatment of recombinant UCH-L3\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro enzymatic assay with oxidative modification; single lab, single method per finding\",\n      \"pmids\": [\"21762696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"UCHL3 associates with the meiotic spindle in oocytes (distinct from UCHL1 at the cortex). Microinjection of anti-UCHL3 antibodies disrupted oocyte maturation, caused abnormally long meiotic spindles, and blocked fertilization, establishing UCHL3 as required for proper meiotic spindle function and oocyte maturation.\",\n      \"method\": \"Microinjection of antibodies/inhibitors into GV oocytes, live-cell imaging, spindle morphology analysis\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by imaging plus functional antibody injection with defined phenotype; single lab\",\n      \"pmids\": [\"21751213\", \"21678411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"UCHL3 deubiquitylates TDP1 (tyrosyl DNA phosphodiesterase 1), controlling its proteostasis. UCHL3 depletion increases TDP1 ubiquitylation and turnover, sensitizing cells to TOP1 poisons. Overexpression of catalytically active (but not inactive) UCHL3 suppresses TDP1 ubiquitylation. UCHL3 is downregulated in SCAN1, correlating with elevated TDP1 ubiquitylation.\",\n      \"method\": \"Knockdown and overexpression with catalytically inactive mutant controls, ubiquitylation assays, TOP1 poison sensitivity assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain/loss-of-function with catalytic mutant control, ubiquitylation assay, and disease-model correlation; multiple orthogonal validations\",\n      \"pmids\": [\"29898404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"UCHL3 interacts with and directly deubiquitylates Ku80, promoting Ku80 retention at DNA double-strand break sites. UCHL3 depletion reduces Ku80 foci and chromatin binding after DSB induction and decreases NHEJ efficiency. DNA damage induces ATM-dependent phosphorylation of UCHL3 (which destabilizes UCHL3 but does not affect its catalytic activity).\",\n      \"method\": \"Co-immunoprecipitation, in vitro deubiquitylation assay, laser micro-irradiation/ChIP, NHEJ reporter assay, kinase inhibitor studies\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct deubiquitylation assay plus reciprocal Co-IP plus functional NHEJ assay; multiple orthogonal methods\",\n      \"pmids\": [\"30559450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UCHL3 deubiquitinates and stabilizes TRAF2 protein, activating NF-κB signaling to promote ovarian cancer tumorigenesis. Genetic ablation of UCHL3 blocked NF-κB activation and cancer cell proliferation/migration.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deubiquitination assay, luciferase NF-κB reporter, knockdown/knockout, xenograft\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus deubiquitination assay plus pathway reporter; single lab\",\n      \"pmids\": [\"31477831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UCHL3 deubiquitinates and stabilizes FOXM1 in pancreatic cancer cells, promoting proliferation, migration, invasion, and gemcitabine resistance. UCHL3 knockdown increased FOXM1 ubiquitination and turnover.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deubiquitination assay, cycloheximide chase, xenograft mouse model\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, in vitro DUB assay, and protein stability assay; single lab with in vivo validation\",\n      \"pmids\": [\"31598398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UCHL3 deubiquitinates RAD51 to promote its recruitment to DNA damage sites and augment homologous recombination repair. Perifosine (an Akt inhibitor) inhibits UCHL3 deubiquitination activity at low dose, induces RAD51 ubiquitination, blocks RAD51-BRCA2 interaction, and reduces IRIF of RAD51.\",\n      \"method\": \"In vitro DUB assay, ubiquitination assay, Co-IP, IRIF foci analysis, HR reporter, xenograft\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro DUB activity assay plus cellular HR assay; single lab\",\n      \"pmids\": [\"31113933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UCHL3 deubiquitinates and stabilizes LSH (lymphoid-specific helicase chromatin remodeler) in non-small cell lung cancer cells; the lncRNA GIAT4RA counteracts this interaction by binding LSH and competing with UCHL3.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, protein stability assay, knockdown/rescue\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and ubiquitination assays showing direct interaction; single lab\",\n      \"pmids\": [\"31417184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"UCHL3 interacts with, deubiquitylates, and stabilizes AhR (aryl hydrocarbon receptor) in NSCLC cells in a deubiquitylation activity-dependent manner, promoting stem-like gene expression (ABCG2, KLF4, c-Myc) and tumorigenic capacity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deubiquitylation assay, catalytic mutant controls, chromatin IP, knockdown/overexpression\",\n      \"journal\": \"Signal transduction and targeted therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, in vitro DUB assay, catalytic mutant, and ChIP; multiple orthogonal methods in one study\",\n      \"pmids\": [\"32546741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"UCHL3 deubiquitylates Aurora B (catalytic subunit of the chromosome passenger complex) and promotes Aurora B localization to kinetochores during mitosis. Downregulation or inhibition of UCHL3 causes chromosome alignment defects and segregation errors during metaphase/anaphase.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitylation assay, immunofluorescence for kinetochore localization, siRNA knockdown, UCHL3 inhibition\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, DUB assay, and localization with functional mitotic phenotype; single lab\",\n      \"pmids\": [\"32738097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Structural modeling and in vitro biochemistry showed that phosphorylation of UCHL3 at Ser75 (mimicked by S75E mutation) enhances deubiquitinating activity toward Ub-AMC and enables cleavage of K48-linked tetra-ubiquitin chains, which the wild-type enzyme cannot cleave at lower chain lengths.\",\n      \"method\": \"Structural simulation of phosphomimetic UCHL3S75E, crystal structure of UCHL3S75E-Ub-PA complex, in vitro DUB activity assay with di/tri/tetra-ubiquitin chains\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural analysis combined with in vitro enzymatic assay using phosphomimetic mutation; single lab\",\n      \"pmids\": [\"36142702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UCHL3 deubiquitylates and stabilizes YAP in anaplastic thyroid cancer cells in a deubiquitylation activity-dependent manner. YAP/TEAD4 in turn transcriptionally activates UCHL3 expression, forming a positive feedback loop.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitylation assay, UCHL3 promoter analysis, ChIP, knockdown/rescue\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, DUB assay, and promoter/ChIP analysis; single lab\",\n      \"pmids\": [\"36813921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mechanical force-stimulated macrophage-derived exosomes enriched in UCHL3 promote BMSC osteogenesis. Mechanistically, UCHL3 interacts with and stabilizes SMAD1 in BMSCs; UCHL3 inhibition downregulates SMAD1 and overexpression of SMAD1 rescues UCHL3-inhibition effects on osteogenesis.\",\n      \"method\": \"Proteomic analysis of exosomes, Co-immunoprecipitation, knockdown/rescue, in vivo orthodontic tooth movement model\",\n      \"journal\": \"Journal of nanobiotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and rescue experiments with in vivo validation; single lab\",\n      \"pmids\": [\"36915132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UCHL3 interacts with and deubiquitylates p300, leading to transcriptional activation of chemokines Ccl2, Ccl7, Ccl12 cooperatively with C/EBPβ, promoting M2 macrophage polarization and pulmonary fibrosis in alveolar type II cells.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, ATII cell-specific knockout, transcriptional analysis\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, DUB assay, cell-specific KO with defined transcriptional and cellular phenotype; single lab\",\n      \"pmids\": [\"37524875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Farrerol directly activates UCHL3 deubiquitinase activity, enhancing RAD51 deubiquitination and promoting homologous recombination repair. UCHL3 ablation significantly attenuates farrerol-mediated HR stimulation, identifying UCHL3 as the direct target of farrerol.\",\n      \"method\": \"Direct binding assay, in vitro DUB activity assay, HR reporter, UCHL3 knockout rescue experiment\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct target identification with in vitro activity assay and genetic ablation rescue; multiple orthogonal methods\",\n      \"pmids\": [\"37012254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UCHL3 interacts with and deubiquitylates Vimentin (via K48-linked chains), enhancing its stability and promoting HCC cell migration; siRNA or TCID inhibitor-mediated suppression of UCHL3 upregulated ubiquitinated Vimentin.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, ubiquitination assay, siRNA knockdown, wound healing/Transwell assays\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP plus ubiquitination assay and functional migration assay; single lab\",\n      \"pmids\": [\"36969045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UCHL3 interacts with and removes K48-linked poly-ubiquitin chains from β-catenin (ARM domain required), stabilizing β-catenin and activating Wnt/TCF target gene expression to promote HCC stem-like properties. UCHL3 depletion induces ferroptosis in HCC cells that is rescued by β-catenin overexpression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, TOP-luciferase reporter, domain mapping, knockdown/rescue\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination assay, domain mapping, and reporter assay; single lab\",\n      \"pmids\": [\"38092274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"UCHL3 deubiquitylates POLD4 (DNA polymerase delta subunit 4) in glioma stem cells, stabilizing it and promoting proneural-to-mesenchymal transition and radiation resistance via maintenance of HR and NHEJ repair.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, deubiquitylation assay, in vitro/in vivo radiation assays, xenograft\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, GST pull-down, and DUB assay with in vivo validation; single lab\",\n      \"pmids\": [\"38829550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"UCHL3 stabilizes CTNNB1 (β-catenin) through deubiquitination, activating Wnt signaling in bladder cancer in a deubiquitylation activity-dependent manner. Uchl3-deficient mice are less susceptible to bladder tumorigenesis.\",\n      \"method\": \"CRISPR-Cas9 knockout/overexpression, Co-IP, RNA-seq, dual-luciferase Wnt reporter, conditional knockout mice\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus pathway reporter plus in vivo conditional KO; single lab\",\n      \"pmids\": [\"37740194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"UCHL3 deubiquitinates RIPK4 at the K469 site, removing K48-linked ubiquitin chains and stabilizing RIPK4. GSK3β-mediated phosphorylation of RIPK4 at Ser420 enhances its interaction with UCHL3, facilitating further deubiquitination and stabilization to promote ovarian cancer metastasis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, site-specific mutagenesis (K469, S420), TCID inhibitor treatment\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, site-specific mutagenesis, ubiquitination assay; single lab\",\n      \"pmids\": [\"38664501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"UCHL3 directly binds EEF1A1 at its lysine site and reduces EEF1A1 ubiquitination, stabilizing it; the UCHL3/EEF1A1 axis promotes HCC migration, stemness, and drug resistance.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, cycloheximide chase, immunofluorescence, xenograft\",\n      \"journal\": \"Biology direct\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and ubiquitination assay with stability measurement; single lab\",\n      \"pmids\": [\"38965582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Chemically constrained peptides identified by RaPID mRNA display bind PfUCHL3 with nanomolar affinity and selectively inhibit its deubiquitinase activity versus human UCHL3. NMR spectroscopy showed the peptides block ubiquitin substrate binding rather than occupying the active site.\",\n      \"method\": \"mRNA display (RaPID), NMR spectroscopy, in vitro DUB activity assay, selectivity profiling\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural mapping of binding site plus in vitro inhibition assay with selectivity data; multiple orthogonal methods\",\n      \"pmids\": [\"38739798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 removes K48-linked polyubiquitin chains from SIPA1 at lysine 805, protecting it from proteasomal degradation; ITCH E3 ligase antagonistically promotes SIPA1 ubiquitination. TRIM21 post-translationally targets UCHL3 for proteasomal degradation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, site-specific mutagenesis (K805), knockdown/rescue\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and ubiquitination assay with site-specific mutagenesis; single lab\",\n      \"pmids\": [\"41412211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 deubiquitinates and stabilizes PKM2 at K206 (C95A active-site mutant cannot do so), promoting pyruvate biosynthesis and augmenting cuproptosis in hepatocellular carcinoma.\",\n      \"method\": \"siRNA library screen, Co-IP, active-site mutagenesis (C95A), ubiquitinome profiling, site-specific mutagenesis (K206R), in vitro and in vivo cuproptosis assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — active-site mutagenesis plus site-specific substrate mutagenesis plus ubiquitinome profiling; single lab\",\n      \"pmids\": [\"40451468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 binds PACRG and stabilizes it via deubiquitination; DNAH10 exerts a bridging effect that enhances UCHL3-PACRG complex interaction to facilitate manchette function during spermiogenesis.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, knockout mouse/cell models, localization studies\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and DUB assay with genetic model; single lab\",\n      \"pmids\": [\"41058558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MC-LR directly binds the catalytic domain of UCHL3, blocking its interaction with GOPC and inhibiting its enzymatic activity, leading to excessive GOPC ubiquitination and proteasomal degradation, disrupting acrosome biogenesis.\",\n      \"method\": \"Direct binding assay, ubiquitination assay, proteasomal degradation assay, knockdown\",\n      \"journal\": \"Environmental pollution\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct binding and enzymatic inhibition with functional acrosome phenotype; single lab\",\n      \"pmids\": [\"40784473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 deubiquitinates and stabilizes HMGB1 by cleaving Lys48-linked polyubiquitin chains, promoting cytoplasmic HMGB1 accumulation, NCOA4-mediated ferritinophagy, and ferroptosis in nucleus pulposus cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, transcriptomics, siRNA knockdown, in vivo disc degeneration model\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, ubiquitination assay, and in vivo model; single lab\",\n      \"pmids\": [\"42169250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 deubiquitinates TFEB, preventing its proteasomal degradation. DOX suppresses TFEB via UCHL3 downregulation, and 20-DOI counteracts DIC by restoring autophagic flux through UCHL3-mediated TFEB deubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, western blot, autophagic flux assays, in vivo MI/R model\",\n      \"journal\": \"Phytomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and functional autophagic assay with in vivo model; single lab\",\n      \"pmids\": [\"40916238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Redox regulation: in S. cerevisiae, accumulated ROS during the diauxic shift inactivate Yuh1 (UCHL3 ortholog) via a thiol-based redox switch, reducing NEDD8/Rub1 maturation and affecting mitochondrial integrity.\",\n      \"method\": \"Yeast genetic model, redox biochemistry, mitochondrial function assays\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast ortholog study with defined redox mechanism and mitochondrial phenotype; single lab\",\n      \"pmids\": [\"40347692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 is activated upon flavivirus (ZIKV/DENV) infection; catalytically inactive UCHL3 C95A fails to rescue viral replication in UCHL3-KO cells. UCHL3 physically associates with sfRNA complexes and its loss accelerates RNase L-dependent sfRNA degradation from P-bodies to RLBs.\",\n      \"method\": \"CRISPR-Cas9 KO, reconstitution with WT vs. C95A mutant, proximity-biotinylation sfRNA-interactome capture, RNase L knockdown epistasis\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — catalytic mutant reconstitution plus proximity interactome plus genetic epistasis; single lab\",\n      \"pmids\": [\"42231789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"c/EBPβ transcriptionally upregulates Uchl3; UCHL3 then deubiquitinates TRPV1 and inhibits its proteasomal degradation in dorsal root ganglion neurons, stabilizing TRPV1 and promoting mitochondrial fission and neuropathic pain.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, cycloheximide chase, luciferase assay, ChIP, CCI rat model with intrathecal siRNA\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, DUB assay, transcriptional assays, and in vivo pain model; single lab\",\n      \"pmids\": [\"41864857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCHL3 deubiquitinates and stabilizes ENO1 by removing K48-linked polyubiquitin chains at lysine 92; a C95A point mutation abolishes this activity. ENO1 stabilization activates the AKT/CCND1 pathway to drive gastric cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, site-specific mutagenesis (C95A, K92), cycloheximide chase, ubiquitination assay, molecular docking, PDX model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — active-site and substrate-site mutagenesis, GST pull-down, ubiquitination assay, and in vivo PDX; multiple orthogonal methods\",\n      \"pmids\": [\"41271634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Genetic lowering of UCHL3 in Huntington's disease neuronal models (primary mouse neurons, patient fibroblasts, patient-derived medium spiny neurons) decreased polyQ aggregates and increased autophagosome-lysosome fusion, accompanied by STAT3 induction. A small-molecule UCHL3 inhibitor recapitulated these neuroprotective effects.\",\n      \"method\": \"siRNA/genetic knockdown, small-molecule inhibitor treatment, autophagy flux assays, aggregate quantification in patient-derived neurons\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological loss-of-function in disease-relevant neuronal models with defined mechanistic readouts; single lab\",\n      \"pmids\": [\"41578740\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UCHL3 is a cysteine deubiquitylase (catalytic triad Cys95-His169-Asp184) and deNEDDylase that uses a crossover-loop-gated active site to cleave ubiquitin and NEDD8 from diverse substrates; phosphorylation of Ser75 and allosteric inhibition by K48-linked ubiquitin dimers modulate its chain-length preference, while its established substrates span DNA-repair factors (TDP1, RAD51, Ku80), oncoproteins (AhR, YAP, TRAF2, FOXM1, β-catenin/CTNNB1, RIPK4), cytoskeletal and metabolic proteins (Vimentin, ENO1, PKM2), signaling regulators (Aurora B, TRPV1, HMGB1, SMAD1, TFEB, PACRG), and ion-channel trafficking (ENaC), making UCHL3 a broad regulator of protein homeostasis in neurons, oocytes, muscle, and cancer cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"UCHL3 is a papain-like cysteine deubiquitylase whose active site is built on a Cys95-His169-Asp184 catalytic triad with an oxyanion-hole glutamine (Gln89), and which hydrolyzes the C-terminus of both ubiquitin and the ubiquitin-like protein NEDD8, distinguishing it from its paralog UCHL1 [#0, #2]. Substrate access is governed by an active-site crossover loop that sterically restricts cleavage of bulky polyubiquitin adducts, such that wild-type UCHL3 favors small ubiquitin substrates while loop enlargement confers gain-of-function polyubiquitin chain cleavage [#1, #5]; this gating is modulated by phosphorylation at Ser75, which enhances activity and permits cleavage of K48-linked tetra-ubiquitin, and by allosteric inhibition from non-covalently bound K48-linked ubiquitin dimers [#21, #8]. The dominant cellular function emerging from the corpus is substrate stabilization: UCHL3 removes K48-linked degradative ubiquitin chains from a broad panel of client proteins, protecting them from proteasomal turnover in a catalysis-dependent manner. Through this activity UCHL3 stabilizes DNA-repair factors including TDP1, Ku80, and RAD51 to support topoisomerase-lesion repair, non-homologous end joining, and homologous recombination [#13, #14, #17]. The same deubiquitylase logic drives its role in cancer, where it stabilizes oncogenic clients such as AhR, YAP, FOXM1, \\u03b2-catenin/CTNNB1, ENO1, and TRAF2 to sustain proliferation, stemness, and survival signaling [#19, #20, #22, #27, #29, #42]. UCHL3 also regulates physiological homeostasis across tissues, controlling ENaC recycling in renal epithelium, meiotic spindle function in oocytes, and neuronal maintenance, where loss in mice causes axonal and dorsal root ganglia degeneration and accumulation of polyubiquitinated proteins [#4, #12, #6, #10]. Its activity is itself redox-sensitive, being impaired by oxidation of catalytic cysteine [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established the structural and catalytic basis of UCHL3 as a cysteine protease, defining the active-site architecture before any substrate was known.\",\n      \"evidence\": \"X-ray crystallography of human UCH-L3 at 1.8 \\u00c5 resolving the Cys95-His169-Asp184 triad and a masked active-site cleft\",\n      \"pmids\": [\"9233788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Unliganded structure did not capture the substrate-bound conformation\", \"Did not define physiological substrates\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed UCHL3 is a dual-specificity C-terminal hydrolase for ubiquitin and NEDD8, distinguishing it functionally from UCHL1.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, and in vitro cleavage assay with recombinant enzyme\",\n      \"pmids\": [\"9790970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish cellular NEDD8 substrates\", \"In vitro context only\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Confirmed the catalytic mechanism with a covalent ubiquitin-suicide-substrate complex and revealed the active-site crossover loop plus tolerance for sizable leaving groups.\",\n      \"evidence\": \"X-ray crystallography at 1.45 \\u00c5 of the ubiquitin-vinylmethylester adduct with in vitro isopeptide hydrolysis\",\n      \"pmids\": [\"15531586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address chain-linkage selectivity in cells\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the crossover loop as the determinant restricting polyubiquitin chain cleavage, explaining why wild-type UCHL3 prefers small substrates.\",\n      \"evidence\": \"Sortagging-based cleavage assays with crossover-loop mutagenesis and in vitro DUB activity tests\",\n      \"pmids\": [\"19047059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Loop dynamics in the presence of physiological substrates not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified an allosteric brake: K48-linked ubiquitin dimers inhibit UCHL3 specifically, providing a feedback mechanism on its activity.\",\n      \"evidence\": \"In vitro binding, cell-based Co-IP, and enzymatic activity assays\",\n      \"pmids\": [\"19154770\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; structural basis of the allosteric site not determined\", \"In vivo relevance of dimer inhibition unestablished\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Provided early in vivo function, showing UCHL3 controls ENaC deubiquitination and recycling in renal epithelium.\",\n      \"evidence\": \"Activity-based probe labeling, knockdown, surface biotinylation, and electrophysiology in CCD cells\",\n      \"pmids\": [\"17967898\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct deubiquitylation of ENaC not reconstituted in vitro\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated genuine in vivo deubiquitinating function required for proteostasis, since catalytically active enzyme is needed to clear polyubiquitin accumulation.\",\n      \"evidence\": \"Uchl3-/- mice, MEF rescue with wild-type vs catalytic/ubiquitin-binding mutants, and in vitro DUB assay\",\n      \"pmids\": [\"20380862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual physiological substrates in muscle not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked UCHL3 loss to tissue-specific degeneration, implicating it in protection against oxidative-stress-driven apoptosis.\",\n      \"evidence\": \"Knockout mouse retina with IHC, EM, and apoptosis-marker westerns\",\n      \"pmids\": [\"16816367\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic substrate linking UCHL3 to mitochondrial stress not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Initiated the substrate-stabilization paradigm by showing UCHL3 deubiquitylates DNA-repair factors to control their proteostasis and the DNA damage response.\",\n      \"evidence\": \"Reciprocal gain/loss-of-function with catalytic mutant controls, ubiquitylation assays, and TOP1-poison/NHEJ readouts for TDP1 and Ku80\",\n      \"pmids\": [\"29898404\", \"30559450\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cellular E3 ligases opposing UCHL3 on these substrates not fully mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended UCHL3 to homologous recombination and to oncogenic client stabilization, framing it as a druggable cancer dependency.\",\n      \"evidence\": \"In vitro DUB and ubiquitination assays, Co-IP, HR/NF-\\u03baB reporters and xenografts for RAD51, TRAF2, FOXM1, and LSH\",\n      \"pmids\": [\"31113933\", \"31477831\", \"31598398\", \"31417184\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most are single-lab studies\", \"Direct vs indirect deubiquitylation not uniformly distinguished\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed that Ser75 phosphorylation reprograms chain-length preference, providing a regulatory switch enabling K48 tetra-ubiquitin cleavage.\",\n      \"evidence\": \"Phosphomimetic S75E modeling, crystal structure of the S75E-Ub-PA complex, and in vitro DUB assays on di/tri/tetra-ubiquitin\",\n      \"pmids\": [\"36142702\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The physiological kinase for Ser75 not identified\", \"Cellular consequences of S75 phosphorylation untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Broadened UCHL3 substrates to mitotic and oncogenic regulators, reinforcing catalysis-dependent stabilization across pathways.\",\n      \"evidence\": \"Co-IP, DUB assays, catalytic-mutant controls, ChIP and localization for AhR and Aurora B\",\n      \"pmids\": [\"32546741\", \"32738097\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Aurora B finding is single-lab\", \"Linkage specificity on each substrate not always defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified small molecules that directly modulate UCHL3 (activator farrerol) and consolidated its broad oncogenic and tissue-homeostasis substrate network.\",\n      \"evidence\": \"Direct binding/activity assays with KO rescue (farrerol/RAD51) plus Co-IP/DUB assays for YAP, Vimentin, \\u03b2-catenin, SMAD1, p300, with in vivo models\",\n      \"pmids\": [\"37012254\", \"36813921\", \"36969045\", \"38092274\", \"36915132\", \"37524875\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Many substrate studies are single-lab\", \"Whether all clients are direct catalytic substrates not uniformly verified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established site-specific deubiquitylation and upstream control of UCHL3, with K48-chain removal at defined substrate lysines and regulation of UCHL3 by phosphorylation and E3 ligases.\",\n      \"evidence\": \"Site-specific substrate mutagenesis (RIPK4-K469, SIPA1-K805), active-site mutants, and Co-IP across CTNNB1, POLD4, EEF1A1, RIPK4, SIPA1\",\n      \"pmids\": [\"38664501\", \"38829550\", \"38965582\", \"37740194\", \"41412211\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab substrate studies\", \"Integration of competing E3 ligases into a unified regulatory model incomplete\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Expanded UCHL3 into metabolism, ferroptosis/cuproptosis, antiviral defense, and disease models, and identified selective peptide and small-molecule modulators.\",\n      \"evidence\": \"Active-site mutant (C95A) and site-specific assays for PKM2/ENO1, ubiquitination/autophagy assays for HMGB1/TFEB/TRPV1/PACRG/GOPC, sfRNA interactome capture, and RaPID peptide inhibitors\",\n      \"pmids\": [\"40451468\", \"41271634\", \"42169250\", \"40916238\", \"41864857\", \"41058558\", \"40784473\", \"42231789\", \"38739798\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mostly single-lab mechanistic claims\", \"Direct vs scaffold roles in antiviral sfRNA protection not fully resolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Linked UCHL3 activity to neurodegenerative proteostasis, showing its inhibition is neuroprotective in Huntington's disease models via enhanced autophagic clearance.\",\n      \"evidence\": \"Genetic and pharmacological loss-of-function in patient-derived neurons with aggregate and autophagy-flux readouts\",\n      \"pmids\": [\"41578740\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct UCHL3 substrate controlling autophagosome-lysosome fusion not identified\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how UCHL3's intrinsic small-substrate preference is reconciled with its many reported K48-polyubiquitin substrate-stabilization events, and which cellular signals (kinases, redox, allosteric ligands) select among its dozens of clients in a given tissue.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of substrate selectivity\", \"Crossover-loop gating vs in-cell polyubiquitin cleavage not reconciled\", \"Endogenous regulators of chain-length switching incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 5, 10, 13, 14]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 2, 5]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [13, 14, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [12, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [13, 14, 17, 28]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [19, 20, 22, 27, 29, 42]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TDP1\", \"Ku80\", \"RAD51\", \"AhR\", \"YAP\", \"CTNNB1\", \"ENO1\", \"TRAF2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}